A detailed history of Ironwood Investment Counsel, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Ironwood Investment Counsel, LLC holds 3,472 shares of LLY stock, worth $2.76 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares
3,472
Previous 3,480 0.23%
Holding current value
$2.76 Million
Previous $3.15 Million 2.38%
% of portfolio
0.54%
Previous 0.59%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $6,177 - $7,680
-8 Reduced 0.23%
3,472 $3.08 Million
Q2 2024

Aug 05, 2024

BUY
$724.87 - $909.04 $37,693 - $47,270
52 Added 1.52%
3,480 $3.15 Million
Q1 2024

May 10, 2024

BUY
$592.2 - $792.28 $592 - $792
1 Added 0.03%
3,428 $2.67 Million
Q4 2023

Feb 07, 2024

BUY
$525.19 - $619.13 $90,332 - $106,490
172 Added 5.28%
3,427 $2 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $3,477 - $4,794
8 Added 0.25%
3,255 $1.75 Million
Q2 2023

Aug 08, 2023

SELL
$350.74 - $468.98 $13,678 - $18,290
-39 Reduced 1.19%
3,247 $1.52 Million
Q1 2023

May 11, 2023

SELL
$310.63 - $364.82 $77,036 - $90,475
-248 Reduced 7.02%
3,286 $1.13 Million
Q4 2022

Feb 01, 2023

SELL
$321.55 - $374.67 $1,607 - $1,873
-5 Reduced 0.14%
3,534 $1.29 Million
Q3 2022

Nov 08, 2022

BUY
$296.48 - $337.87 $44,768 - $51,018
151 Added 4.46%
3,539 $1.14 Million
Q2 2022

Aug 04, 2022

SELL
$278.73 - $327.27 $28,709 - $33,708
-103 Reduced 2.95%
3,388 $1.1 Million
Q1 2022

May 09, 2022

SELL
$234.69 - $291.66 $17,601 - $21,874
-75 Reduced 2.1%
3,491 $999,000
Q3 2021

Nov 04, 2021

BUY
$221.6 - $272.71 $44,320 - $54,541
200 Added 5.94%
3,566 $823,000
Q2 2021

Aug 06, 2021

SELL
$180.55 - $233.54 $18,055 - $23,354
-100 Reduced 2.89%
3,366 $772,000
Q1 2021

May 03, 2021

SELL
$164.32 - $212.72 $22,840 - $29,568
-139 Reduced 3.86%
3,466 $647,000
Q4 2020

Feb 11, 2021

BUY
$130.46 - $172.63 $154,203 - $204,048
1,182 Added 48.78%
3,605 $608,000
Q3 2020

Nov 16, 2020

BUY
$146.22 - $169.13 $5,117 - $5,919
35 Added 1.47%
2,423 $358,000
Q2 2020

Aug 11, 2020

BUY
$136.42 - $164.18 $3,546 - $4,268
26 Added 1.1%
2,388 $392,000
Q4 2019

Feb 10, 2020

BUY
$106.92 - $132.43 $17,321 - $21,453
162 Added 7.36%
2,362 $310,000
Q3 2018

Oct 23, 2018

BUY
$85.86 - $107.31 $188,892 - $236,082
2,200 New
2,200 $236,000
Q3 2017

Oct 30, 2017

SELL
$77.07 - $85.54 $562,611 - $624,442
-7,300 Closed
0 $0
Q2 2017

Aug 11, 2017

BUY
N/A
7,300
7,300 $601,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Ironwood Investment Counsel, LLC Portfolio

Follow Ironwood Investment Counsel, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ironwood Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ironwood Investment Counsel, LLC with notifications on news.